Illumina
Genomics platform company enabling sequencing across research, clinical, and applied markets.
Typical Backgrounds
Types of experience professionals commonly develop
Roles Companies Often Recruit
Common roles when hiring Illumina-caliber talent
- Principal Scientists
- Clinical Development Leaders
- Regulatory Affairs
- Medical Science Liaisons
- Bioinformatics Scientists
- Executive Leadership
Related Resources
Salary guides, hiring guides, market reports and case studies
Illumina's role as the genomics infrastructure company
Illumina is the dominant sequencing platform provider across research, clinical, and applied genomics markets, which makes it the training ground for a large share of the industry's bioinformatics and sequencing-chemistry talent. Nearly every genomics-driven biotech, diagnostics company, or techbio has someone who cut their teeth on Illumina instruments or software.
Recruits Lab sees the strongest demand for Illumina alumni in clinical bioinformatics and sequencing applications science, since those roles sit at the intersection of hardware, software, and regulated clinical use, a combination that is hard to find fully formed anywhere else.
Org structure and titles that matter
Illumina organizes around Instrument Engineering (hardware and chemistry), Software and Bioinformatics, Clinical and Applied Markets, and Regulatory Affairs for its clinical-grade products. Titles to know: Director and Senior Director of Sequencing Chemistry, Director of Bioinformatics Software, Director of Clinical Affairs, and Director of Regulatory Affairs for IVD-cleared products.
Illumina's Applications Science group produces field-facing scientists who bridge instrument capability and customer use cases, a hybrid technical-commercial skill set that transfers well to any genomics company selling into research or clinical labs.
Hiring bar and interview process
Illumina's engineering and chemistry interviews are hardware-and-wetlab intensive, often requiring candidates to walk through troubleshooting a real sequencing run or chemistry failure mode. Bioinformatics roles include a technical coding and pipeline-design assessment, reflecting the scale of genomic data Illumina's platforms generate.
Clinical affairs and regulatory interviews focus on IVD and companion-diagnostic regulatory pathways, since Illumina has navigated FDA clearance for multiple sequencing-based clinical products, a genuinely differentiated body of experience.
Compensation posture
| Level / Function | Typical Total Comp Range | Equity Form | Notes |
|---|---|---|---|
| Senior Director, Sequencing Chemistry | $240K–$310K | Illumina RSUs | Deep chemistry IP is a differentiator |
| Director, Bioinformatics Software | $220K–$290K | Illumina RSUs | Large-scale genomic pipeline experience |
| Director, Clinical Affairs | $210K–$270K | Illumina RSUs | IVD and companion diagnostic exposure |
| Director, Regulatory Affairs (IVD) | $220K–$280K | Illumina RSUs | FDA clearance experience is scarce and valuable |
| Senior Applications Scientist | $150K–$200K | Illumina RSUs, smaller grants | Field-facing, hybrid technical-commercial role |
Which profiles transfer well, and where
A frequent transition out of Illumina is an Applications Scientist or Director of Clinical Affairs moving into a diagnostics or precision-medicine startup that is building its first regulatory and clinical strategy, since Illumina's IVD clearance experience is genuinely rare in the broader genomics ecosystem.
| Origin Team | Strengths | Best-Fit Destination | Watch-Outs |
|---|---|---|---|
| Sequencing Chemistry | Deep wet-lab and hardware-chemistry integration knowledge | Genomics instrument startup or next-gen sequencing challenger | IP and non-compete considerations matter more here than in most biotech moves |
| Bioinformatics Software | Large-scale genomic data pipeline architecture | Precision medicine techbio or clinical genomics diagnostics company | Startup infrastructure and data volumes are usually smaller in scope |
| Clinical Affairs / Regulatory (IVD) | FDA clearance experience for sequencing-based clinical products | Diagnostics company pursuing its first IVD or companion diagnostic clearance | Every company's specific assay and indication changes the regulatory strategy |
| Applications Science | Hybrid technical-commercial customer-facing skill | Genomics tools company building out field science team | Requires travel and customer-site work most corporate roles don't |
How to recruit out of Illumina
Motivators: interest in working on a smaller, more focused product versus Illumina's broad platform portfolio, and appetite for equity upside after years of large-cap RSU comp. Blockers: IP assignment and, in some chemistry and hardware roles, non-compete or non-solicit terms that require careful review before a competing sequencing company can extend an offer.
Illumina's San Diego headquarters anchors a large in-person engineering and chemistry workforce, though bioinformatics and clinical affairs roles have more remote flexibility. Counter-offers tend to focus on internal transfer into newer product lines (like multi-omics or spatial platforms) rather than large cash increases, so recruiters should be ready to explain why an external role offers something Illumina's own product roadmap cannot.
Frequently asked questions
Are there non-compete concerns when hiring from Illumina into a competing sequencing company?
Yes, particularly for sequencing chemistry and instrument engineering roles where Illumina has historically protected core IP. Recruiters should confirm the candidate's specific agreement terms and role overlap early, since direct-competitor moves in chemistry can trigger real legal review.
Why is Illumina IVD regulatory experience valuable to diagnostics startups?
Illumina has navigated FDA clearance for multiple sequencing-based clinical products, including companion diagnostics, which is a genuinely rare body of experience. Diagnostics startups pursuing their first clearance often need that specific regulatory pattern recognition.
What does Illumina's bioinformatics interview process look like?
Candidates typically complete a technical coding assessment and a pipeline-design discussion focused on handling genomic data at scale, reflecting the volume and complexity of data generated across Illumina's sequencing platform installed base.
How does Illumina's Grail divestiture affect its talent market position?
The Grail spin-off separated Illumina's core sequencing platform business from its cancer-screening diagnostics ambitions, meaning candidates should clarify which entity a resume line refers to, since the two now have distinct regulatory and commercial talent profiles.
What functions is Illumina currently expanding?
Illumina continues to invest in next-generation sequencing chemistry to defend against emerging competitors, along with multi-omics and spatial biology-adjacent software, which is driving hiring in both wet-lab chemistry and bioinformatics software roles.